Perioperative Chemotherapy with Docetaxel Plus Oxaliplatin and S-1 (DOS) Versus Oxaliplatin Plus S-1 (SOX) for the Treatment of Locally Advanced Gastric or Gastro-Esophageal Junction Adenocarcinoma (MATCH): an Open-Label, Randomized, Phase 2 Clinical Trial